How did our predictions from last year fare? Highlights from luxury, health and finance.
Our annual Future 100 report dives into the trends, innovation, and cultural changes that will drive the next year. How did last year’s predictions fare? Below, we look back at our most accurate predictions in luxury, health and finance.
Wellness architecture (#75)
Indoor environments are being constructed for optimal health, thanks to a growing focus on purified air.
- Purified air is becoming a sought-after amenity for house hunters. At Charlotte of the Upper West Side, a new luxury apartment building in Manhattan scheduled to open in 2021, each of the seven units will be outfitted with state-of-the-art air filtration technologies that purify the air by treating it with ultraviolet light.
- Hotels, too, are touting virus-scrubbed air as the latest amenity. The Distillery Inn in Colorado uses an anti-viral HVAC system with germicidal ultraviolet light to conduct a three-hour disinfection cycle between guests.
- The boutique Hotel Paso del Norte in Texas recently installed an air purification system called Plasma Air that emits charged ions to neutralize and filter out virus particles.
- New York governor Andrew Cuomo issued a mandate in June that all malls in the state are required to upgrade their air filtration systems in order to open.
Psychedelic health (#82)
Psilocybin, the active ingredient that gives mushrooms their psychotropic properties, is gaining recognition as an alternative treatment and being decriminalized.
- In November, Oregon became the first state to legalize magic mushrooms for mental health treatments.
- San Francisco senator Scott Wiener has announced plans to introduce a bill in 2021 to decriminalize psychedelics.
- Johns Hopkins researchers published findings in November proving that psilocybin, when combined with psychotherapy, is four times as effective as traditional antidepressants. The study comes almost a year after the university opened a center for psychedelic research with $17 million in funding.
- As psilocybin treatment gains legitimacy, companies specializing in the psychedelic therapy are attracting investors’ attention. Shares of Compass Pathways, which patented a synthetic version of psilocybin to treat depression, jumped 71% in September. Shares of MindMed have surged over 50% since the beginning of December and have more than tripled since the end of October.
- Psychedelic drug startup ATAI Life Sciences closed a $125 million Series C financing round in November. The German company is exploring the use of magic mushrooms and other psychedelics to treat mental health disorders.
Financial therapy (#95)
The emotional side of personal finance is coming the fore—paving the way for a swathe of companies offering a more holistic approach to financial management.
- The pandemic has increased financial anxiety and is driving a growing demand for financial therapy, the New York Times reported in May.
- Chicago-based psychology practice The Planning Center believes that money management requires not just rational thinking, but emotional intelligence. To account for this, the practice has started bringing psychological principles and practices to financial planning.
- Origin thinks financial wellness should be an employee benefit. The San Francisco based start-up raised $12 million in funding in June 2020 for its financial wellness platform that offers companies financial planning for their employees.
- Emma, a personal finance management app that bills itself as users’ BFF—”best financial friend”—raised $2.5 million in seed funding in March 2020. “In a world where 70% of mental health issues are derived by financial problems, Emma is defining a new category, financial therapy,” says Emma founder and CEO Edoardo Moreni.
Main image of Charlotte of the Upper West Side. Rendering credit: Depict.